Werewolf Therapeutics
Price & Volume
Stats
See more52W Range | $0.53-$2.38 |
Market Cap | $26.6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$50.4M |
Diluted EPS | -$1.62 |
News
See moreYahoo Finance • 2 months ago
MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26
Yahoo Finance • 4 months ago
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Yahoo Finance • 6 months ago
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
Yahoo Finance • 8 months ago
Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
About
CEO | Dr. Daniel J. Hicklin Ph.D. |
CFO | Mr. Timothy W. Trost CPA |
Address | 200 Talcott Ave, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 39 |
